Generali Asset Management SPA SGR bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 132,689 shares of the real estate investment trust’s stock, valued at approximately $2,690,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its holdings in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after purchasing an additional 4,056,931 shares during the last quarter. Thrivent Financial for Lutherans bought a new stake in shares of Healthpeak Properties during the third quarter worth about $1,880,000. Pathstone Holdings LLC bought a new stake in shares of Healthpeak Properties during the third quarter worth about $1,968,000. Swedbank AB bought a new stake in shares of Healthpeak Properties during the third quarter worth about $1,832,000. Finally, Associated Banc Corp bought a new stake in shares of Healthpeak Properties during the third quarter worth about $10,559,000. Institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Price Performance
Shares of DOC opened at $20.43 on Thursday. Healthpeak Properties, Inc. has a 52-week low of $17.29 and a 52-week high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The business’s 50 day moving average price is $20.23 and its two-hundred day moving average price is $21.20. The firm has a market cap of $14.29 billion, a PE ratio of 58.36, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14.
Healthpeak Properties Increases Dividend
Wall Street Analyst Weigh In
DOC has been the topic of several research reports. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Scotiabank cut their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research note on Friday, February 28th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Thursday, March 13th. Mizuho cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Finally, Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $23.92.
Check Out Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Profitably Trade Stocks at 52-Week Highs
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Why Are These Companies Considered Blue Chips?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- ESG Stocks, What Investors Should Know
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.